In the peripheral blood T lymphocytes and serum samples of breast cancer survivors who had received adjuvant chemotherapy, the expressions of p16INK4a and ARF increased, and the expressions of multiple SASP factors in the serum were significantly higher than those in patients who had not received adjuvant chemotherapy. This evidence concerns the gene CDKN2A and breast cancer.